Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Matthew Britz

Premium

Retrogenix has named Matthew Britz as its North American business development director. Britz will operate out of the UK firm's newly established US office in Cambridge, Mass. He previously served as director of business development at Evory Therapeutics and earlier in his career held scientific and managerial positions at Pfizer, Merck, and Acambis.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.